Biora Therapeutics Unveils Groundbreaking Presentation
Biora Therapeutics, Inc. (NASDAQ: BIOR) is excited to announce that its leadership team will be taking part in the upcoming 19th Annual Peptide Therapeutics Symposium. This event is a significant opportunity for the biotech community, bringing together leading experts in peptide research from various sectors dedicated to enhancing drug discovery and therapeutic development.
Innovative Presentation Highlights
A highlight of the symposium is a presentation titled "Empowering Peptide Self-Administration with Needle Free Smart Capsules." The event will take place virtually and in person, allowing for a wide reach of attendees interested in peptide-based innovations. This presentation is set for October 22, 2024, from 2:30 PM to 3:00 PM PT, offering a brief window into the transformative work being undertaken by Biora.
Keynote Presenter
The presentation will be delivered by Sharat Singh, PhD, Head of Research at Biora Therapeutics. Dr. Singh's expertise and insights into peptide therapeutics promise to enlighten attendees on the latest advancements and applications within this critical field.
Symposium Overview
The Peptide Therapeutics Symposium stands as a beacon for researchers and developers in the biopharmaceutical industry. Attendees can expect discussions surrounding the latest core technologies that pertain to peptide drug discovery and the enhancement of therapeutic candidates. With the event gathering top minds in the industry, the exchange of innovative ideas is anticipated to flourish.
About Biora Therapeutics
Biora Therapeutics is at the forefront of clinical-stage biotechnology, focusing on developing innovative, smart pill-based therapeutic platforms. Chief among these efforts is the NaviCap™ platform, designed specifically for the colon-targeted treatment of inflammatory bowel disease (IBD). This innovative approach aims to optimize patient outcomes through localized treatment. Additionally, the company is advancing its BioJet™ platform, which facilitates the oral delivery of larger molecules that traditionally required injection, thereby providing a needle-free alternative for managing chronic conditions.
Explore More
If you want to learn more about Biora Therapeutics and its pioneering projects, you can visit their official website or follow them on professional networking platforms to stay updated on their continuous advancements in healthcare.
Frequently Asked Questions
What is Biora Therapeutics known for?
Biora Therapeutics is a clinical-stage biotech company renowned for developing innovative smart pill-based therapeutics platforms aimed at improving patient care.
What will Biora present at the symposium?
Biora will present on the topic "Empowering Peptide Self-Administration with Needle Free Smart Capsules," highlighting advancements in peptide drug delivery.
Who is the presenter for Biora at the event?
The presentation will be delivered by Sharat Singh, PhD, who is the Head of Research at Biora Therapeutics.
When is the Peptide Therapeutics Symposium?
The symposium will take place on October 22-23, 2024, with Biora's presentation scheduled for October 22.
How does Biora's technology benefit patients?
Biora's technology enhances therapeutic delivery through smart pills, targeting treatment areas more effectively and reducing the need for injections, thereby improving patient compliance and outcomes.